Aridis Pharmaceuticals (ARDS) Revenue & Revenue Breakdown
Aridis Pharmaceuticals Revenue Highlights
Latest Revenue (Q)
$417.00K
Aridis Pharmaceuticals Revenue by Period
Aridis Pharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | -100.00% |
| 2020-12-31 | $1.00M | -2.15% |
| 2019-12-31 | $1.02M | -62.93% |
| 2018-12-31 | $2.76M | 220.58% |
| 2017-12-31 | $860.00K | -62.10% |
| 2016-12-31 | $2.27M | - |
Aridis Pharmaceuticals generated - in revenue during NA 2022, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Aridis Pharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2023-09-30 | $417.00K | -97.88% |
| 2023-06-30 | $19.65M | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | -100.00% |
| 2022-06-30 | $292.00K | 100.00% |
| 2022-03-31 | - | -100.00% |
| 2021-12-31 | $570.00K | 481.63% |
| 2021-09-30 | $98.00K | 196.97% |
| 2021-06-30 | $33.00K | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | -100.00% |
| 2020-06-30 | $1.00M | 100.00% |
| 2020-03-31 | - | -100.00% |
| 2019-12-31 | $-1.02M | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | -100.00% |
| 2019-03-31 | $1.02M | -26.53% |
| 2018-12-31 | $1.39M | 36.11% |
| 2018-09-30 | $1.02M | 4545.45% |
| 2018-06-30 | $22.00K | -93.17% |
| 2018-03-31 | $322.00K | -62.56% |
| 2017-12-31 | $860.00K | 3809.09% |
| 2017-09-30 | $22.00K | - |
| 2017-06-30 | $22.00K | - |
| 2017-03-31 | $22.00K | - |
Aridis Pharmaceuticals generated $417.00K in revenue during Q3 2023, up -97.88% compared to the previous quarter, and up 142.81% compared to the same period a year ago.
Aridis Pharmaceuticals Revenue Breakdown
Aridis Pharmaceuticals Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 19 | Dec 18 |
|---|---|---|
| License | - | - |
| Collaboration Revenue | - | $1.17M |
Quarterly Revenue by Product
| Product/Service | Jun 22 | Sep 21 | Jun 21 | Sep 18 | Jun 18 |
|---|---|---|---|---|---|
| Grant Revenue | $292.00K | - | - | - | - |
| License | - | $98.00K | $33.00K | - | - |
| Grant | - | $417.00K | $1.02M | $22.00K | - |
Aridis Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Jun 22: Grant Revenue (100.00%).
Aridis Pharmaceuticals Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 19 | Dec 18 |
|---|---|---|
| License | - | - |
| Collaboration Revenue | - | $1.17M |
Quarterly Revenue by Country
| Country | Jun 22 | Sep 21 | Jun 21 | Sep 18 | Jun 18 |
|---|---|---|---|---|---|
| Grant Revenue | $292.00K | - | - | - | - |
| License | - | $98.00K | $33.00K | - | - |
| Grant | - | $417.00K | $1.02M | $22.00K | - |
Aridis Pharmaceuticals's latest quarterly revenue breakdown by geography, as of Jun 22: Grant Revenue (100.00%).
Aridis Pharmaceuticals Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| SGTX | Sigilon Therapeutics | $12.94M | $5.90M |
| UNCY | Unicycive Therapeutics | $675.00K | - |
| ADTX | Aditxt | $645.18K | $44.28K |
| ABVC | ABVC BioPharma | $152.43K | $117.14K |
| VRAX | Virax Biolabs Group | $8.56K | $76.50K |
| NRBO | NeuroBo Pharmaceuticals | $7.00K | - |
| EYEN | Eyenovia | $3.79K | $4.99K |
| RVPH | Reviva Pharmaceuticals | - | - |
| REVB | Revelation Biosciences | - | - |
| AKTX | Akari Therapeutics | - | - |
| ARDS | Aridis Pharmaceuticals | - | $417.00K |
| CGTX | Cognition Therapeutics | - | - |
| DRMA | Dermata Therapeutics | - | - |
| HOTH | Hoth Therapeutics | - | - |
| ATXI | Avenue Therapeutics | - | - |
| ZVSA | ZyVersa Therapeutics | - | - |
| KOD | Kodiak Sciences | - | - |
| RNAZ | TransCode Therapeutics | - | - |
| ACST | Acasti Pharma | - | - |
ARDS Revenue FAQ
What is Aridis Pharmaceuticals’s yearly revenue?
Aridis Pharmaceuticals's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. The company's yearly revenue for 2021 was $0, representing a decrease of -100.00% compared to 2020. ARDS's yearly revenue for 2020 was $1M, representing a decrease of -2.15% compared to 2019.
What is Aridis Pharmaceuticals’s quarterly revenue?
Aridis Pharmaceuticals's quarterly revenue for Q3 2023 was $417K, a -97.88% decrease from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022). The company's quarterly revenue for Q2 2023 was $19.65M, a 100.00% increase from the previous quarter (Q1 2023), and a 6628.42% increase year-over-year (Q2 2022). ARDS's quarterly revenue for Q1 2023 was $0, a 100.00% increase from the previous quarter (Q4 2022), and a 0% increase year-over-year (Q1 2022).
What is Aridis Pharmaceuticals’s revenue growth rate?
Aridis Pharmaceuticals's revenue growth rate for the last 3 years (2020-2022) was -100.00%, and for the last 5 years (2018-2022) was -100.00%.